GoKawiil
Neurocrine to Buy Soleno for Treatment for Rare Disease That Causes Relentless Hunger
(feeds.content.dowjones.io)
1.
2.
Neurocrine to Buy Soleno for $2.9 Billion
(feeds.content.dowjones.io)
3.
Biogen to Acquire Apellis Pharmaceuticals for $5.6 Billion
(feeds.content.dowjones.io)
4.
AI succeeds in diagnosing rare diseases
(feeds.nature.com)
5.
How DeepMind’s genome AI could help solve rare-disease mysteries
(feeds.nature.com)
6.
How DeepMind's genome AI could help solve rare disease mysteries
(feeds.nature.com)
Today's top topics:
apple
openai
nasa
samsung
google
artemis ii
android authority
moon
orion spacecraft
microsoft